Chimera Investment (CIM) Cash & Equivalents (2009 - 2026)

Chimera Investment (CIM) has 17 years of Cash & Equivalents data on file, last reported at $476.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 87.97% year-over-year to $476.2 million; the trailing twelve-month figure through Mar 2026 stood at $476.2 million (up 87.97% YoY), and the FY2025 full-year result was $278.6 million, up 231.65% from the prior year.
• Cash & Equivalents improved to $476.2 million in Q1 2026, from $278.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $491.5 million in Q3 2025 to a low of $84.0 million in Q4 2024.
• A 5-year average of $219.5 million and a median of $200.9 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents plunged 73.75% in 2022 and surged 404.98% in 2025, its largest moves.
• Tracing CIM's Cash & Equivalents over 5 years: stood at $264.6 million in 2022, then slipped by 16.22% to $221.7 million in 2023, then tumbled by 62.11% to $84.0 million in 2024, then surged by 231.65% to $278.6 million in 2025, then surged by 70.94% to $476.2 million in 2026.
• Business Quant data shows CIM's Cash & Equivalents at $476.2 million in Q1 2026, $278.6 million in Q4 2025, and $491.5 million in Q3 2025.